Skip to main content
SpringerLink
Log in

Paraoxonase 1, atherosclerosis and arterial stiffness in renal patients

  • Nephrology – Review
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Atherosclerosis is an important contributor to increased cardiovascular burden in populations with and without renal disease. Paraoxonases (PON) are a group of enzymes that hydrolyse organophosphates. Recent evidence indicates a protective role for PON in patients with coronary artery disease and atherosclerosis. Although data are limited, the low enzyme activity found in patients with chronic kidney disease and renal transplants has been linked to atherosclerosis and arterial stiffness. In this paper, we review the emerging role of PON1 in the pathophysiology of atherosclerosis and arterial stiffness in patients with chronic kidney disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sarnak MJ, Foley RN (2011) Cardiovascular mortality in the general population versus dialysis: a glass half full or empty? Am J Kidney Dis 58:4–6

    Article  PubMed  Google Scholar 

  2. Recio-Mayoral A, Banerjee D, Streather C, Kaski JC (2011) Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease—a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 216:446–451

    Article  PubMed  CAS  Google Scholar 

  3. Kuchta A, Pacanis A, Kortas-Stempak B et al (2011) Estimation of oxidative stress markers in chronic kidney disease. Kidney Blood Press Res 34:12–19

    Article  PubMed  CAS  Google Scholar 

  4. Brunet P, Gondouin B, Duval-Sabatier A et al (2011) Does uremia cause vascular dysfunction? Kidney Blood Press Res 34:284–290

    Article  PubMed  CAS  Google Scholar 

  5. Van Craeyveld E, Gordts SC, Jacobs F, De Geest B. (2011) Correlation of atherosclerosis between different topographic sites is highly dependent on the type of hyperlipidemia. Heart Vessel. doi:10.1007/s00380-010-0098-9

  6. Ok E, Basnakian AG, Apostolov EO, Barri YM, Shah SV (2005) Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease. Kidney Int 68:173–178

    Article  PubMed  CAS  Google Scholar 

  7. Mackness MI, Durrington PN, Mackness B (2004) The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention. Am J Cardiovasc Drugs 4:211–217

    Article  PubMed  CAS  Google Scholar 

  8. Précourt LP, Amre D, Denis MC et al (2011) The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis 214:20–36

    Article  PubMed  Google Scholar 

  9. Mackness MI, Mackness B, Durrington PN (2002) Paraoxonase and coronary heart disease. Atheroscler Suppl 3:49–55

    Article  PubMed  CAS  Google Scholar 

  10. Reiner E, Svedruzic D, Simeon-Rudolf V, Lipovac V, Gavella M, Mrzljak V (1999) Paraoxonase and arylesterase activities in the serum of two hyperlipoproteinaemic patients after repeated extracorporal lipid precipitation. Chem Biol Interact 119–120:405–411

    Article  PubMed  Google Scholar 

  11. Seo D, Goldschmidt-Clermont P (2009) The paraoxonase gene family and atherosclerosis. Curr Atheroscler Rep 11:182–187

    Article  PubMed  CAS  Google Scholar 

  12. La Du BN, Aviram M, Billecke S et al (1999) On the physiological role(s) of the paraoxonases. Chem Biol Interact 14:379–388

    Google Scholar 

  13. Yildiz A, Gur M, Yilmaz R et al (2008) Association of paraoxonase activity and coronary blood flow. Atherosclerosis 197:257–263

    Article  PubMed  CAS  Google Scholar 

  14. Dantoine TF, Debord J, Charmes JP et al (1998) Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 9:2082–2088

    PubMed  CAS  Google Scholar 

  15. Hambali Z, Ahmad Z, Arab S, Khazaai H (2011) Oxidative stress and its association with cardiovascular disease in chronic renal failure patients. Indian J Nephrol 21:21–25

    Article  PubMed  CAS  Google Scholar 

  16. Tartan Z, Orhan G, Kasikçioglu H et al (2007) The role of paraoxonase (PON) enzyme in the extent and severity of the coronary artery disease in type-2 diabetic patients. Heart Vessels 22:158–164

    Article  PubMed  Google Scholar 

  17. Agachan B, Yilmaz H, Isbir T, Akoglu E (2004) Paraoxonase 192 polymorphism and its relationship to serum lipids in Turkish renal transplant recipients. Transpl Proc 36:1385–1386

    Article  CAS  Google Scholar 

  18. Wang M, Lang X, Zou L, Huang S, Xu Z (2011) Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: a meta-analysis based on 88 case-control studies. Atherosclerosis 214:377–385

    Article  PubMed  CAS  Google Scholar 

  19. Mackness B, Durrington PN, Mackness MI (1998) Human serum paraoxonase. Gen Pharmacol 31:329–336

    Article  PubMed  CAS  Google Scholar 

  20. Hu Y, Tian H, Liu R (2003) Gln-Arg192 polymorphism of paraoxonase 1 is associated with carotid intima-media thickness in patients of type 2 diabetes mellitus of Chinese. Diabetes Res Clin Pract 61:21–27

    Google Scholar 

  21. Chen Q, Reis SE, Kammerer CM et al (2003) Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored women’s ischemia syndrome evaluation (WISE) study. Am J Hum Genet 72:13–22

    Google Scholar 

  22. Imai Y, Morita H, Kurihara H et al (2000) Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis 149:435–442

    Google Scholar 

  23. Liu R, Bai H, Deng J, Liu Y, Huang M, Li X, Liu B (2001) The paraoxonase Gln-Arg192 polymorphism in patients with coronary heart disease in Chinese population. Hua Xi Yi Ke Da Xue Xue Bao 32:385–388

    Google Scholar 

  24. Malin R, Järvinen O, Sisto T, Koivula T, Lehtimäki T (2001) Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis. Atherosclerosis 157:301–307

    Google Scholar 

  25. Schmidt H, Schmidt R, Niederkorn K et al (1998) Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian stroke prevention study. Stroke 29:2043–2048

    Google Scholar 

  26. Arca M, Ombres D, Montali A et al (2002) PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism in an Italian population. Eur J Clin Invest 32(1):9–15

    Google Scholar 

  27. Hofer SE, Bennetts B, Chan AK et al (2006) Association between PON 1 polymorphisms, PON activity and diabetes complications. J Diabetes Complicat 20:322–328

    Article  PubMed  Google Scholar 

  28. Harangi M, Seres I, Magyar MT et al (2008) Association between human paraoxonase 1 activity and intima-media thickness in subjects under 55 years of age with carotid artery disease. Cerebrovasc Dis 25:122–128

    Article  PubMed  CAS  Google Scholar 

  29. Yang WI, Lee SH, Ko YG et al (2010) Relationship between paraoxonase-1 activity, carotid intima-media thickness and arterial stiffness in hypertensive patients. J Hum Hypertens 24:492–494

    Article  PubMed  Google Scholar 

  30. Covic A, Gusbeth-Tatomir P, Goldsmith DJ (2005) Arterial stiffness in renal patients: an update. Am J Kidney Dis 45:965–977

    Article  PubMed  Google Scholar 

  31. Yildiz M, Simsek G, Uzun H, Uysal S, Sahin S, Balci H (2010) Assessment of low-density lipoprotein oxidation, paraoxonase activity, and arterial distensibility in epileptic children who were treated with anti-epileptic drugs. Cardiol Young 20:547–554

    Article  PubMed  Google Scholar 

  32. Gungor O, Kircelli F, Demirci MS et al (2011) Serum paraoxonase 1 activity predicts arterial stiffness in renal transplant recipients. J Atheroscler Thromb 18:901–905

    Article  PubMed  CAS  Google Scholar 

  33. Ciftci H, Savas M, Yeni E, Verit A, Celik H, Oncel H (2010) Serum paraoxonase activity in patients with low glomerular filtration rates. Ren Fail 32:562–565

    Article  PubMed  CAS  Google Scholar 

  34. Dirican M, Akca R, Sarandol E, Dilek K (2004) Serum paraoxonase activity in uremic predialysis and hemodialysis patients. J Nephrol 17:813–818

    PubMed  CAS  Google Scholar 

  35. Saeed SA, Elsharkawy M, Elsaeed K, Fooda O (2008) Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients. Hemodial Int 12:471–479

    Article  PubMed  Google Scholar 

  36. Cheung AK (2009) Is lipid control necessary in hemodialysis patients? Clin J Am Soc Nephrol 4:95–101

    Article  Google Scholar 

  37. Dirican M, Sarandol E, Serdar Z, Ocak N, Dilek K (2007) Oxidative status and prevalent cardiovascular disease in patients with chronic renal failure treated by hemodialysis. Clin Nephrol 68:144–150

    PubMed  CAS  Google Scholar 

  38. Gugliucci A, Mehlhaff K, Kinugasa E et al (2007) Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance. Clin Chim Acta 377:213–220

    Article  PubMed  CAS  Google Scholar 

  39. Schiavon R, De Fanti E, Giavarina D, Biasioli S, Cavalcanti G, Guidi G (1996) Serum paraoxonase activity is decreased in uremic patients. Clin Chim Acta 247:71–80

    Article  PubMed  CAS  Google Scholar 

  40. Itahara T, Suehiro T, Ikeda Y et al (2000) Serum paraoxonase and arylesterase activities in hemodialysis patients. J Atheroscler Thromb 7:152–158

    PubMed  CAS  Google Scholar 

  41. Paragh G, Asztalos L, Seres I et al. (1999) Serum paraoxonase activity changes in uremic and kidney-transplanted patients. Nephron 83:126–131

    Google Scholar 

  42. Juretic D, Tadijanovic M, Rekic B, Simeon-Rudolf V, Reiner E, Baricic M (2001) Serum paraoxonase activities in hemodialyzed uremic patients: cohort study. Croat Med J 42:146–150

    PubMed  CAS  Google Scholar 

  43. Sutherland WH, de Jong SA, Walker RJ (2004) Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study. Nephrol Dial Transplant 19:75–82

    Google Scholar 

  44. Paragh G, Seres I, Balogh Z et al (1998) The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia. Nephron 80:166–170

    Article  PubMed  CAS  Google Scholar 

  45. Ak G, Ozgönül M, Sözmen EY, Aslan SL, Sözmen B (2002) Renal cortical thickness and PON1 activity both decrease in chronic renal failure. J Nephrol 15:144–149

    PubMed  CAS  Google Scholar 

  46. Henning BF, Holzhausen H, Tepel M (2010) Continuous reduction of plasma paraoxonase activity with increasing dialysis vintage in hemodialysis patients. Ther Apher Dial 14:572–576

    Article  PubMed  CAS  Google Scholar 

  47. Emre H, Keles M, Yildirim S et al (2011) Comparison of the oxidant-antioxidant parameters and sialic acid levels in renal transplant patients and peritoneal dialysis patients. Transpl Proc 43:809–812

    Article  CAS  Google Scholar 

  48. Liberopoulos EN, Papavasiliou E, Miltiadous GA et al (2004) Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis. Perit Dial Int 24:580–589

    PubMed  CAS  Google Scholar 

  49. Lentine KL, Hurst FP, Jindal RM et al (2010) Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis 55:152–167

    Article  PubMed  Google Scholar 

  50. Hasselwander O, Savage DA, McMaster D et al (1999) Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients. Kidney Int 56:289–298

    Article  PubMed  CAS  Google Scholar 

  51. Mirdamadi HZ, Sztanek F, Derdak Z, Seres I, Harangi M, Paragh G (2008) The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters. Br J Clin Pharmacol 66:366–373

    Article  PubMed  CAS  Google Scholar 

  52. Paragh G, Seres I, Harangi M et al (2006) Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome. Br J Clin Pharmacol 61:694–701

    Article  PubMed  CAS  Google Scholar 

  53. Blatter-Garin MC, Kalix B, De Pree S, James RW (2003) Aspirin use is associated with higher serum concentrations of the antioxidant enzyme, paraoxonase-1. Diabetologia 46:593–594

    PubMed  CAS  Google Scholar 

  54. Turfaner N, Uzun H, Balci H et al (2010) Ezetimibe therapy and its influence on oxidative stress and fibrinolytic activity. South Med J 103:428–433

    Article  PubMed  Google Scholar 

  55. Marsillach J, Martinez-Vea A, Marcas L et al (2007) Administration of exogenous erythropoietin b affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anemia. Clin Exp Pharmacol Physiol 34:347–349

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Division of Nephrology, Ege University School of Medicine, 35100, Bornova, Izmir

    Ozkan Gungor, Fatih Kircelli & Huseyin Toz

Authors
  1. Ozkan Gungor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fatih Kircelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Huseyin Toz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ozkan Gungor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gungor, O., Kircelli, F. & Toz, H. Paraoxonase 1, atherosclerosis and arterial stiffness in renal patients. Int Urol Nephrol 45, 441–447 (2013). https://doi.org/10.1007/s11255-012-0197-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-012-0197-x

Keywords

Search

Navigation